Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Vitamin B6, Calcium Pantothenate, Nicotinamide & Folic Acid Capsule
Pack Sizes Available
Product Description
Technical Specifications
- Composition: Methylcobalamin 1500mcg + Alpha Lipoic Acid 100mg + Benfotiamine 100mg + Vitamin B6 3mg + Calcium Pantothenate 12.5mg + Nicotinamide 50mg + Folic Acid 1.5mg per softgel
- Dosage Form: Softgel capsule
- Drug Class: Neurotropic vitamin and antioxidant combination
- Route of Administration: Oral
- Pack Configuration: 10x1x10 softgels, unit carton
- Storage Conditions: Store below 25 degrees Celsius, protect from light and moisture
This formula is used as a supportive therapy for peripheral neuropathy, particularly diabetic neuropathy, alongside standard diabetes management, helping support nerve repair, reduce oxidative stress, and address related nutritional deficiencies.
Methylcobalamin supports nerve myelin repair, Alpha Lipoic Acid acts as an antioxidant against nerve-damaging oxidative stress, Benfotiamine supports nerve metabolism through an efficiently absorbed form of vitamin B1, and Vitamin B6, Calcium Pantothenate, Nicotinamide, and Folic Acid support broader nerve cell function and red blood cell formation.
This formula is commonly prescribed for patients experiencing diabetic neuropathy, alcoholic neuropathy, or other peripheral nerve conditions causing burning, tingling, or numbness, usually alongside management of the underlying condition.
It is typically taken orally once daily, with or without food, as directed by the treating physician, and should not be chewed or crushed.
Softgel capsules should be stored in a cool, dry place, protected from light and moisture, at a temperature not exceeding 25 degrees Celsius.
Yes, we support contract manufacturing and private label arrangements for distributors and pharmaceutical companies looking to build their own branded version of this neuropathy support combination.
Related Products
Explore more high-quality items from our Neurology & Psychiatry (CNS) range.
Cerebroprotein Hydrolysate for Injection 60mg
Once a stroke or brain injury protocol calls for a more intensive dose, the 60mg strength of Cerebroprotein Hydrolysate for Injection is typically where treatment moves. It carries double the nitrogen-equivalent content of the 30mg presentation, and it is the strength most commonly reached for in adult patients undergoing active stroke rehabilitation, recovery from traumatic brain injury, or management of cognitive decline linked to neurodegenerative conditions such as Alzheimer's and Parkinson's disease. This is a peptide-based neurotrophic agent, derived from purified brain protein, that works by supporting the survival and repair of damaged neurons and encouraging the kind of synaptic plasticity the brain relies on during recovery from injury or progressive decline. It is not a standalone cure for any of these conditions, but it has become a well-established part of the broader treatment toolkit neurologists and rehabilitation specialists draw on, typically alongside physical therapy, cognitive rehabilitation, and other supportive care. Sara Wellness has built its export business over fifteen years around exactly this kind of specialized injectable, where fewer manufacturers compete and buyers need a partner who actually understands the product rather than a generic pharma trading house. We source this from GMP-certified Indian manufacturing facilities, and because it is a more technical product than a standard antibiotic, our team is equipped to answer detailed questions about composition, dosing protocols, and batch-to-batch consistency without deferring you to a separate technical department. We keep the relationship with every buyer direct, whether that is a rehabilitation hospital ordering for the first time or an established distributor managing supply across multiple neurology clinics in a region. Our minimum order quantities are structured to make a first trial order accessible without requiring the commitment of a full container, while still supporting the larger recurring orders that hospital networks with standing stroke protocols typically need. Every shipment ships with certificate of analysis, GMP compliance documentation, and export paperwork tailored to your destination country's regulatory requirements. If your hospital, rehabilitation center, or distribution business is building out a neurology and stroke recovery formulary and needs a dependable source for Cerebroprotein Hydrolysate, reach out with your target country and expected order size, and our team will respond with current pricing and realistic delivery timelines based on actual production schedules.
Cerebroprotein Hydrolysate for Injection 30mg
Recovery after a stroke or a serious head injury is rarely a straight line, and a lot of what neurologists are actually trying to do in those early weeks is give the brain's own repair mechanisms a better chance to work. Cerebroprotein Hydrolysate for Injection is built around that idea. It is a peptide-based neurotrophic agent derived from purified brain protein, used to support nerve cell recovery and protect neurons from further damage during acute and chronic brain-related conditions. The 30mg strength delivers a lower-nitrogen-equivalent dose commonly used in less severe cases, in pediatric and lower body weight patients, or as a starting dose in treatment protocols that scale up gradually. Clinically, this category of injectable is used across a range of neurological situations, including stroke rehabilitation, traumatic brain injury recovery, and cognitive decline associated with conditions like Alzheimer's disease, where supporting neuronal survival and synaptic function is part of the broader treatment strategy alongside physical and cognitive rehabilitation. For hospitals and neurology-focused clinics building out a rehabilitation and neuroprotection formulary, having a reliable, well-documented source for this category of injectable matters more than it might for a more commoditized product, simply because fewer manufacturers specialize in it. Sara Wellness has spent fifteen years building direct relationships with GMP-certified Indian manufacturers across a wide therapeutic range, including specialized neurology injectables like this one, and we bring the same documentation discipline to this product that we apply to our critical care antibiotic lines. We work one on one with hospital procurement teams, rehabilitation centers, and distributors rather than routing orders through intermediaries who add cost without adding value. That direct relationship matters particularly for a specialized neurology product, where questions about dosing protocols, batch consistency, and regulatory documentation tend to be more technical than a standard antibiotic order. Our MOQs are set to work for smaller neurology clinics testing this product for the first time as well as larger hospital networks incorporating it into standing stroke and brain injury protocols. Every shipment ships with certificate of analysis, GMP compliance documentation, and export paperwork prepared for your destination country's specific regulatory requirements. If your hospital, rehabilitation center, or distribution business is looking to add a dependable source for Cerebroprotein Hydrolysate to your neurology portfolio, reach out with your target country and expected order size and we will respond with current pricing and realistic delivery timelines.